• 1. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 2. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 3. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 4. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 5. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acid esters

(R)-2-(2-(tert-butoxy)-2-oxoethyl)pentanoic acid: A Comprehensive Overview

(R)-2-(2-(tert-butoxy)-2-oxoethyl)pentanoic acid, identified by the CAS number 112106-16-8, is a compound of significant interest in the fields of organic chemistry and pharmacology. This compound, with its unique structure, has garnered attention due to its potential applications in drug development and as a building block in organic synthesis. The molecule consists of a pentanoic acid backbone with a substituted ethyl group, where the substituents include a tert-butoxy group and a ketone moiety. These structural features contribute to its distinct chemical properties and reactivity.

The synthesis of (R)-2-(2-(tert-butoxy)-2-oxoethyl)pentanoic acid typically involves multi-step organic reactions, often leveraging stereochemistry to achieve the desired configuration at the chiral center. Recent advancements in asymmetric catalysis have enabled more efficient and selective methods for synthesizing this compound, reducing production costs and enhancing purity. The use of biocatalysts, such as lipases or enzymes, has also been explored to facilitate enantioselective syntheses, further underscoring its importance in green chemistry.

From a physical standpoint, this compound exhibits a melting point of approximately 135°C and is sparingly soluble in water but readily dissolves in organic solvents like dichloromethane and ethyl acetate. Its solubility characteristics make it suitable for various analytical techniques, including high-performance liquid chromatography (HPLC) and nuclear magnetic resonance (NMR) spectroscopy. The presence of the tert-butoxy group imparts steric hindrance, which influences the compound's reactivity in nucleophilic substitutions and other transformations.

Recent studies have highlighted the potential of (R)-2-(2-(tert-butoxy)-2-oxoethyl)pentanoic acid as an intermediate in the synthesis of bioactive molecules. For instance, researchers have employed this compound as a precursor in the development of peptide-based drugs targeting various therapeutic areas, including oncology and neurodegenerative diseases. Its role as an intermediate allows for the construction of complex molecular architectures with high precision.

In terms of biological activity, preliminary assays have demonstrated that this compound exhibits moderate inhibitory effects on certain enzymes implicated in inflammatory processes. While these findings are still in their early stages, they suggest potential avenues for further exploration in drug discovery programs. Collaborative efforts between academic institutions and pharmaceutical companies are currently underway to assess its pharmacokinetic profile and safety parameters.

The application of computational chemistry tools has significantly enhanced our understanding of the molecular properties of (R)-2-(2-(tert-butoxy)-2-oxoethyl)pentanoic acid. Quantum mechanical calculations have provided insights into its electronic structure, enabling predictions about its reactivity under different reaction conditions. Additionally, molecular docking studies have revealed potential binding modes with target proteins, offering valuable guidance for rational drug design.

Looking ahead, the continued investigation into the properties and applications of this compound is expected to yield further breakthroughs. Its versatility as both a synthetic intermediate and a potential therapeutic agent positions it as a key player in future research endeavors. As advancements in synthetic methodology and biological screening continue to evolve, so too will our understanding of this intriguing molecule.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)